US FDA panel okays COVID-19 booster jabs for people over 65
Al Jazeera
Recommendation comes after science advisory panel rejects Pfizer proposal to provide booster jabs to most people.
A United States Food and Drug Administration (FDA) advisory panel has given approval to a booster jab of the Pfizer COVID-19 vaccine for people over the age of 65 and others at high risk of the disease.
But the influential FDA panel of scientists on Friday rejected widespread delivery of boosters to most Americans, delivering a surprise blow to the Biden administration’s plan to combat the highly contagious Delta variant by rolling out third jabs of the vaccine next week.
Members of the FDA’s panel of outside experts voted unanimously to support boosters for older Americans and at-risk people after rejecting Pfizer’s proposal to provide boosters of the vaccine to the general public.
Parliament voted later in the evening requiring President Yoon to lift the martial law he declared earlier.
These were the key developments on the 1,014th day of the Russia-Ukraine war.
Millions of Palestinians face the threat of famine as food supplies reach new lows.
Taijul Islam’s five-for helps the visitors win the second Test at Sabina Park and level the two-match series.
The US aims to grow its influence in sub-Saharan Africa.
These were the key developments on the 1,014th day of the Russia-Ukraine war.
Parliament voted later in the evening requiring President Yoon to lift the martial law he declared earlier.
Israeli forces have attacked residential buildings, shelters for displaced people and public facilities in Gaza City.
The attack comes as violence in Syria intensifies, with opposition fighters advancing against government positions.
The tech firm says its defences were able to defeat AI-driven misinformation operations from gaining an online foothold.
Nandi-Ndaitwah, 72, won with 57 percent of the vote, flouting predictions that she might be forced into a run-off.